Latozinemab

· Alector

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Latozinemab, covering 2026-01-21 to 2026-01-21. Get the full timeline:

Most recent: Clinical Trial Update: Continuation Study for Latozinemab [Phase 3]